Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of pancreatic cancer.

× No keyword cloud information.

11 in total

Review 1. Adjuvant and neoadjuvant therapies of pancreatic cancer: a review.

Authors: J Harris; H Bruckner
Journal: Int J Pancreatol Date: 2001

2. Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective.

Authors: J A van Heerden
Journal: World J Surg Date: 1984-12 Impact factor: 3.352

3. Serologic markers in the diagnosis and management of pancreatic carcinoma.

Authors: D K Podolsky
Journal: World J Surg Date: 1984-12 Impact factor: 3.352

4. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.

Authors: W U Shipley; W C Wood; J E Tepper; A L Warshaw; E L Orlow; S D Kaufman; G E Battit; G L Nardi
Journal: Ann Surg Date: 1984-09 Impact factor: 12.969

5. Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro.

Authors: R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

6. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.

Authors: B Szende; A Zalatnai; A V Schally
Journal: Proc Natl Acad Sci U S A Date: 1989-03 Impact factor: 11.205

Review 7. Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.

Authors: D Perilli; C Mansi; V Savarino; G Celle
Journal: Int J Pancreatol Date: 1993-06

8. [Perioperative staging and the Münster TNM classification in ampullary and pancreatic cancer].

Authors: M Clemens; J Meyer; U Sulkowski; W Sasse; H Bünte
Journal: Langenbecks Arch Chir Date: 1985

9. Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo.

Authors: R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal: Invest New Drugs Date: 1988-12 Impact factor: 3.850

10. Studies of pancreatic cancer utilizing monoclonal antibodies.

Authors: M Büchler; H Friess; P Malfertheiner; K H Schultheiss; K H Muhrer; H P Kraemer; H G Beger
Journal: Int J Pancreatol Date: 1990 Aug-Nov